12 Health Care Stocks Moving In Monday's Pre-Market Session

 

Gainers

  • iSpecimen ISPC stock rose 31.09% to $6.45 during Monday's pre-market session. The company's market cap stands at $44.9 million.
  • Provention Bio PRVB shares rose 20.99% to $7.55. The company's market cap stands at $478.4 million.
  • CASI Pharmaceuticals CASI shares moved upwards by 12.58% to $1.05. The market value of their outstanding shares is at $146.7 million.
  • Molecular Partners MOLN shares rose 10.33% to $11.53. The company's market cap stands at $372.2 million.
  • Verastem VSTM stock rose 9.45% to $3.24. The market value of their outstanding shares is at $590.2 million.
  • bluebird bio BLUE shares increased by 9.25% to $11.69. The market value of their outstanding shares is at $819.5 million.
  •  

Losers

  • 4d pharma LBPS stock fell 6.07% to $6.82 during Monday's pre-market session. The company's market cap stands at $153.7 million.
  • Amryt Pharma AMYT shares fell 5.96% to $10.9. The company's market cap stands at $693.2 million.
  • MorphoSys MOR stock decreased by 4.69% to $9.96. The company's market cap stands at $1.3 billion.
  • Voyager Therapeutics VYGR shares decreased by 4.26% to $3.15. The company's market cap stands at $119.5 million.
  • Xenetic Biosciences XBIO stock declined by 4.06% to $1.42. The market value of their outstanding shares is at $19.0 million.
  • Acer Therapeutics ACER stock fell 3.85% to $2.25. The market value of their outstanding shares is at $32.1 million. As per the press release, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLUE Logo
BLUEbluebird bio Inc
$4.96-0.40%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
7.80
Growth
Not Available
Quality
Not Available
Value
34.15
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Comments
Loading...